Lulu Xue | Drug | Innovative Research Award

Published on by Research Chemistry Awards

Innovative Research Award

Lulu Xue
Affiliation Nanjing University
Country China
Scopus ID 56310961600
Documents 52
Citations 2,918
h-index 28
Subject Area Drug
Event International Research Chemistry Awards
ORCID 0000-0001-5719-1336

Lulu Xue is a researcher affiliated with Nanjing University, China, whose documented scholarly profile includes research documents, citations, and an h-index. The profile identifies Drug as the principal subject area. These bibliometric indicators provide a quantitative description of research activity and scholarly visibility and are considered here as part of an academic recognition profile rather than as an independent measure of research quality.[1]

Abstract

This article documents the academic recognition profile of Lulu Xue of Nanjing University, China, in connection with the Innovative Research Award of the International Research Chemistry Awards. The supplied research record identifies documents, citations, and an h-index, with Drug listed as the principal subject area. The profile is considered from the perspective of scholarly productivity, citation impact, research relevance, and potential contribution to drug-related chemical research.[1]

Keywords

Lulu Xue of Nanjing University contributes to drug research, medicinal chemistry, and drug discovery through chemical research. Her scholarly profile supports recognition under the Innovative Research Award of the International Research Chemistry Awards, reflecting sustained academic activity and contributions to advancing chemistry-based approaches relevant to pharmaceutical research and scientific innovation.[1]

Introduction

Drug-oriented chemical research encompasses the discovery, design, synthesis, characterization, evaluation, and optimization of chemical entities with potential biological activity. Medicinal chemistry is closely connected with chemical biology, pharmacology, analytical chemistry, and related disciplines, requiring integration of molecular structure, physicochemical properties, biological activity.[2]

Research Profile

The supplied profile associates Lulu Xue with Nanjing University in China and identifies Drug as the relevant subject area. The record contains documents, indicating a substantial body of indexed scholarly output. A citation count of and an h-index further indicate that the publications have received considerable attention within the indexed research literature.[2]

Research Contributions

A contribution in this area may involve the generation of new chemical knowledge, development or optimization of molecular structures, investigation of chemical mechanisms, or application of chemical methodologies to problems in drug discovery and development. Assessment of individual contributions should be based on the scientific content of the corresponding publications and supporting evidence.[3]

Publications

The supplied profile records documents for Lulu Xue. This figure indicates a substantial indexed publication record, although the available input does not provide the individual publication titles, journals, publication years, authorship positions, or article-level citation data. Accordingly, this article does not attribute specific scientific findings to individual publications without corresponding bibliographic evidence.[4]

Research Impact

The supplied citation count of and h-index indicate that the research outputs associated with the supplied Scopus author record have accumulated substantial scholarly citation activity. Citation-based measures can assist in describing the visibility and influence of a research portfolio, but citation frequency varies considerably among disciplines, publication types, research topics, and publication ages. They should therefore be interpreted together with qualitative evidence.[2]

Award Suitability

Based on the information supplied, Lulu Xue presents a research profile that is compatible with consideration for an Innovative Research Award within a chemistry-focused recognition program. The combination of a drug-related subject area, documented research documents, citations, and an h-index of provides measurable evidence of sustained scholarly activity and research visibility.[3]

Conclusion

Lulu Xue of Nanjing University is presented in the supplied academic record as a researcher working in the Drug subject area, with documents, citations, and an h-index . These indicators describe a substantial scholarly publication and citation record and provide quantitative context for consideration within the Innovative Research Award category.[4]

References

    1. Elsevier. (n.d.). Scopus author details: Lulu Xue, Author ID 56310961600. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=56310961600
    2. ORCID. (n.d.). ORCID record: Lulu Xue, ORCID iD 0000-0001-5719-1336. ORCID.
      https://orcid.org/0000-0001-5719-1336
    3. International Research Chemistry Awards. (n.d.).
      https://researchchemistry.org
    4. Gu, Z., Xiong, X., Chen, X., Zhang, H., Gu, N., & Xue, L. (2026). Ligand-mediated reprogramming redirects liver-tropic ionizable lipid nanoparticles for lung-selective mRNA delivery. Angewandte Chemie International Edition.
      https://doi.org/10.1002/anie.6080664

Kushagra Khanna | Pharmacy | Innovative Research Award

Published on by Research Chemistry Awards

Innovative Research Award

Kushagra Khanna
Affiliation UCSI University
Country Malaysia
Scopus ID 57213100648
Documents 57
Citations 898
h-index 16
Subject area Pharmacy
Award Innovative Research Award
Event International Research Chemistry Awards
ORCID 0000-0002-1882-2120

Kushagra Khanna is a researcher affiliated with UCSI University, Malaysia, whose stated subject area is pharmacy. The supplied bibliometric profile records documents, citations and an h-index. These indicators provide a quantitative overview of the research output and citation activity associated with the supplied Scopus author profile. The researcher is recognized in connection with the Innovative Research Award under the International Research Chemistry Awards. The award profile highlights the importance of research innovation, scientific contributions and the advancement of pharmaceutical knowledge.[1]

Abstract

This article presents an academic recognition profile for Kushagra Khanna of UCSI University, Malaysia, in the subject area of pharmacy. The profile is associated with the Innovative Research Award presented under the International Research Chemistry Awards. According to the supplied Scopus information, the researcher has 57 documents, 898 citations and an h-index.[1]

Keywords

Kushagra Khanna; Pharmacy Research; Pharmaceutical Sciences; Innovative Research Award; Pharmaceutical Innovation; Drug Discovery; Clinical Pharmacy; Research Impact; Bibliometrics; Citation Analysis; UCSI University; Malaysia; Scopus Author Profile; ORCID Profile; International Research Chemistry Awards.[2]

Introduction

Pharmacy is a multidisciplinary field concerned with medicines, their development, formulation, safe use and therapeutic applications. Research in this area can connect pharmaceutical sciences with healthcare delivery, pharmacology, drug analysis, medication safety and emerging therapeutic technologies.[1]

Research Profile

The supplied profile identifies Kushagra Khanna with UCSI University, Malaysia, and designates pharmacy as the relevant subject area. The provides a persistent route to the researcher’s indexed author record, while the supports identification of the researcher’s scholarly identity. These identifiers can help readers distinguish an author’s record from similarly named researchers and locate associated academic information .[5]

Research Contributions

Pharmacy research encompasses a broad range of scientific and professional activities, including the investigation of drug properties, pharmaceutical formulations, therapeutic effectiveness, medicine quality and the responsible use of medicines. Depending on the researcher’s documented publication record, contributions in these areas may include experimental studies, analytical methods, literature reviews, translational investigations or collaborative research.[4]

Publications

The supplied Scopus profile records documents associated with the researcher. This document count indicates indexed scholarly output in the source profile, but the figure alone does not establish the types of publications, authorship positions, publication venues or specific scientific findings. Those details should be assessed by reviewing the individual records and their full bibliographic information.[2]

Research Impact

The supplied bibliometric indicators for Kushagra Khanna comprise documents, citations and an h-index. In bibliometric analysis, document counts summarize indexed output, citation counts measure recorded citations, and the h-index combines publication volume with citation frequency. These indicators describe different aspects of scholarly activity and should be interpreted together with subject context and publication-level evidence.[3]

Award Suitability

The profile associates Kushagra Khanna with the Innovative Research Award under the International Research Chemistry Awards. Within the context of pharmacy and pharmaceutical sciences, research innovation may involve new scientific approaches, improved methods, interdisciplinary investigations or evidence that advances understanding of medicines and their applications.[4]

Conclusion

Kushagra Khanna is identified in the supplied information as a pharmacy researcher affiliated with UCSI University, Malaysia, and associated with the Innovative Research Award under the International Research Chemistry Awards. The profile records documents, citations and an h-index. These figures provide a quantitative snapshot of indexed scholarly activity, while a fuller understanding of the researcher’s contributions requires examination of individual publications and verifiable evidence.[5]

References

    1. Elsevier. (n.d.). Scopus author details: Kushagra Khanna, Author ID 57213100648. Scopus. Author profile and bibliometric information should be consulted for current records.
      https://www.scopus.com/authid/detail.uri?authorId=57213100648
    2. ORCID. (n.d.). ORCID record: 0000-0002-1882-2120. ORCID provides a persistent identifier for distinguishing researchers and connecting scholarly contributions.
      https://orcid.org/0000-0002-1882-2120
    3. International Research Chemistry Awards. (n.d.).
      https://researchchemistry.org
    4. Kumar, P., Khanna, K., Dhiani, B. A., Tan, L. F., Yap, V. L., Chow, J. C., & Kaur, C. P. (2026). Targeting uterine fibroid cells with TC-16A: A polyherbal formulation based strategy involving apoptosis, cell cycle arrest, and autophagy. South African Journal of Botany, 196, 477–488.
      https://doi.org/10.1016/j.sajb.2026.04.040
    5. Karwasra, R., Bano, N., Ahmad, S., Singh, S., Khanna, K., Sharma, N., Raza, K., & Verma, S. (2026). Multimodal evaluation of mannose engineered poly lactic glycolic acid nanoparticles with granulocyte colony stimulating factor focused delivery to bone marrow for neutropenia. Scientific Reports, 16, Article 2849.
      https://doi.org/10.1038/s41598-025-29790-w

Parvaiz Ahmad Dar | Organic Synthesis and Medicinal Chemistry | Young Scientist Award

Published on by Research Chemistry Awards

Dr. Parvaiz Ahmad Dar | Organic Synthesis and Medicinal Chemistry | Young Scientist Award

University of Kashmir Srinagar Jammu and Kashmir India | India

A dedicated researcher in chemistry with expertise in organic synthesis, drug design, and computational studies, Organic Synthesis and Medicinal Chemistry focused on developing innovative organic molecules with biomedical and photoluminescent applications. Possesses strong experience in synthesizing and characterizing novel compounds, alongside proficiency in advanced analytical techniques such as spectroscopic methods and molecular characterization tools. Demonstrates solid knowledge of computational chemistry, including density functional theory, molecular modeling, docking, and in silico screening for drug discovery. Research work also extends to carbon nanodots, exploring their photoluminescent properties and potential biomedical applications. Additional exposure to phytochemistry of medicinal plants highlights an interdisciplinary approach toward discovering bioactive compounds. Skilled in laboratory practices, data interpretation, and experimental design, with foundational experience in cell culture and microbial assays.Has contributed to academic development through supervising postgraduate research projects and conducting laboratory instruction, fostering both theoretical understanding and practical skills in chemistry. Actively engaged in advancing research outcomes with a focus on impactful publications, collaborative projects, and innovative scientific contributions. Combines experimental and computational approaches to address complex chemical and biological challenges, reflecting a strong commitment to scientific advancement and applied research.

Citation Metrics (Google Scholar)

400
300
200
100
0

Citations
260

Documents
9

h-index
6

Citations

Documents

h-index


View Google Scholar Profile

Featured Publications

Prof. Pei-Wen Cheng | Medicinal Chemistry | Women Researcher Award

Published on by Research Chemistry Awards

Prof. Pei-Wen Cheng | Medicinal Chemistry | Women Researcher Award

Prof. Pei-Wen Cheng is a distinguished academic and researcher specializing in nanomedicine, pharmacology, and metabolic syndrome. She has built a strong career through dedicated research and teaching, advancing innovative approaches in medical sciences. Her academic journey spans several prestigious institutions in Taiwan and abroad, reflecting her global perspective and commitment to scientific excellence. With expertise rooted in natural product research, pharmacological studies, and biomedical applications, she has made significant contributions to the field. Prof. Cheng continues to drive impactful research while mentoring students and collaborating with colleagues, establishing herself as a respected figure in medical education and biomedical research.

Kaohsiung Veterans General Hospital | Taiwan

Author Profile

Google Scholar

Academic Journey

Prof. Pei-Wen Cheng earned her Ph.D. degree from Kaohsiung Medical University’s Graduate Institute of Natural Products. She further advanced her career through postdoctoral research at the Faculty of Medicine, Dalhousie University and later at the Department of Medical Education and Research, Kaohsiung Veterans General Hospital (Taiwan), where she deepened her expertise in medical sciences.

Professional Career

Prof. Cheng began her academic role as an Assistant Professor at National Sun Yat-sen University while also serving as an Assistant Researcher at Kaohsiung Veterans General Hospital. She then advanced to the position of Associate Professor at National Sun Yat-sen University and Associate Researcher at the hospital, where she contributed significantly to both teaching and research. She is currently a Professor at National Sun Yat-sen University, recognized for her impactful contributions to science and education.

Research Interests

Her primary research focuses on nanomedicine, pharmacology, and metabolic syndrome. Prof. Cheng’s innovative work bridges the gap between nanotechnology and biomedical applications, aiming to develop novel therapeutic strategies that improve human health and address critical challenges in modern medicine.

Notable Publications

Current mechanistic concepts in ischemia and reperfusion injury
Authors: Meng-Yu Wu, Giou-Teng Yiang, Wan-Ting Liao, Andy Po-Yi Tsai, Yeung-Leung Cheng, Pei-Wen Cheng, Chia-Ying Li, Chia-Jung Li
Journal: Cellular Physiology and Biochemistry
Year: 2018

Application of time series analysis in modelling and forecasting emergency department visits in a medical centre in Southern Taiwan
Authors: Wang-Chuan Juang, Sin-Jhih Huang, Fong-Dee Huang, Pei-Wen Cheng, Shue-Ren Wann
Journal: BMJ Open
Year: 2017

Resveratrol decreases fructose‐induced oxidative stress, mediated by NADPH oxidase via an AMPK‐dependent mechanism
Authors: Pei‐Wen Cheng, Wen‐Yu Ho, Yu‐Ting Su, Pei‐Jung Lu, Bo‐Zone Chen, Wen‐Han Cheng, Wen‐Hsien Lu, Gwo‐Ching Sun, Tung‐Chen Yeh, Michael Hsiao, Ching‐Jiunn Tseng
Journal: British Journal of Pharmacology
Year: 2014

Angiotensin II inhibits neuronal nitric oxide synthase activation through the ERK1/2-RSK signaling pathway to modulate central control of blood pressure
Authors: Wen-Han Cheng, Pei-Jung Lu, Wen-Yu Ho, Che-Se Tung, Pei-Wen Cheng, Michael Hsiao, Ching-Jiunn Tseng
Journal: Circulation Research
Year: 2010

Effect of resveratrol on reactive oxygen species-induced cognitive impairment in rats with angiotensin II-induced early Alzheimer’s disease
Authors: Yu-Te Lin, Yi-Chung Wu, Gwo-Ching Sun, Chiu-Yi Ho, Tzyy-Yue Wong, Ching-Huang Lin, Hsin-Hung Chen, Tung-Chen Yeh, Chia-Jung Li, Ching-Jiunn Tseng, Pei-Wen Cheng
Journal: Journal of Clinical Medicine
Year: 2018

Caffeine intake improves fructose-induced hypertension and insulin resistance by enhancing central insulin signaling
Authors: Tung-Chen Yeh, Chun-Peng Liu, Wen-Han Cheng, Bo-Rong Chen, Pei-Jung Lu, Pei-Wen Cheng, Wen-Yu Ho, Gwo-Ching Sun, Jau-Cheng Liou, Ching-Jiunn Tseng
Journal: Hypertension
Year: 2014

Conclusion 

Prof. Pei-Wen Cheng exemplifies dedication to advancing scientific knowledge and fostering innovation in medical research. Her career journey from doctoral studies to professorship reflects her commitment to academic excellence and impactful research. With a focus on nanomedicine, pharmacology, and metabolic syndrome, she continues to push the boundaries of biomedical science. Her contributions extend beyond research, encompassing teaching, mentorship, and international collaborations that strengthen academic networks. As a professor, she remains committed to inspiring future scientists while pursuing groundbreaking discoveries. Prof. Cheng’s work demonstrates how multidisciplinary approaches can contribute to improved healthcare outcomes and scientific advancement on a global scale.

Dr. Cesira Giordano, Medicinal Chemistry, Women Researcher Award

Published on by Research Chemistry Awards

Dr. Cesira Giordano, Medicinal Chemistry, Women Researcher Award

Doctorate at Azienda Opedaliero-Universitaria Pisana, Italy

Professional Profiles

Scopus

Orcid

🎓 Education and Academic Background

Cesira Giordano, born on January 28, 1987, holds a Master’s Degree in Molecular Biology, with a specialization in Microbiology and Virology. She furthered her expertise by completing a 2nd level Master’s in OMIC Data Analysis, reflecting her commitment to integrating cutting-edge technology into her field.

🧑‍🔬 Professional Qualifications and Current Role

Since October 2019, Cesira has held a permanent position as a Biologist Manager at the Hospital Microbiology Department of Azienda Ospedaliero-Universitaria Pisana (AOUP) in Pisa. As a Clinical Microbiologist, she is responsible for key microbiological analyses, including regional control measures in line with Tuscany’s Decree No. 16286 of 2017. Cesira’s work ensures public health laboratories maintain their high standards, particularly through her role as the Single EQA (External Quality Assessment) contact person for SD Hospital Microbiology at AOUP.

🏆 Leadership in Public Health and Tender Commissions

Cesira has been actively involved in public health laboratory management, serving as a Tender Commissioner for various public health tenders in 2023 and 2024. Her roles include:

  • June 2024: Tender Commissioner for AOUP ESTAR, overseeing consumables and accessories for public health laboratories.
  • September 2023: Tender Commissioner for AOUP, focusing on microbiological identifications and antibiotic testing (Antibiograms).
  • July 2023–Ongoing: AOUP Contact Person for the Tuscany Region regarding communications about Listeria monocytogenes.

🔬 Research Contributions and Innovations

Cesira’s research focuses on the development and application of innovative microbiological technologies. Between 2018 and 2019, she was awarded a research grant to develop Fourier Transform Infrared Spectroscopy (FTIR) technology for identifying bacteria and yeast. This work, conducted in collaboration with the University of Pisa, has laid the groundwork for bacterial typing and investigating antibiotic resistance.

Her other research highlights include:

2018: Development of rapid antibiogram protocols for multi-organ donor samples, under the supervision of Dr. Simona Barnini.

2017: Analysis of the genomes of Klebsiella pneumoniae using Next Generation Sequencing (NGS) techniques. This project aimed at identifying new genes responsible for antibiotic resistance, carried out under the leadership of Dr. Simona Barnini.

🌍 International Research and Collaboration

In 2016, Cesira expanded her research experience internationally, spending time at the University Medical Center Groningen (UMCG), Netherlands. There, she worked on whole genome sequencing of multi-resistant Klebsiella pneumoniae strains, contributing to the understanding of antibiotic resistance mechanisms under the guidance of Prof. Dr. Alexander Friedrich, Dr. Erik Bathoorn, and Dr. John Rossen.

🧪 Pioneering Work in Microbiological Diagnostics

Cesira has made significant strides in rapid diagnostic methodologies. In 2016, she played a crucial role in developing rapid molecular and phenotypic antibiograms aimed at diagnosing sepsis swiftly. The protocols she helped develop reduced diagnostic time to as little as 3-6 hours after blood culture positivity, using advanced techniques like MALDI TOF MS. These advancements have greatly improved clinical response times in critical cases, saving lives.

Publications Top Noted📚

Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections

Authors: Shields, R.K., Dorazio, A.J., Tiseo, G., Doi, Y., Falcone, M.

Journal: JAC-Antimicrobial Resistance

Year: 2024

Glycine restores the sensitivity to antibiotics in multidrug-resistant bacteria

Authors: Giordano, C., Barnini, S.

Journal: Microbiology Spectrum

Year: 2024

Clinical Features and Outcomes of Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales: A 3-Year Prospective Study from an Endemic Area

Authors: Falcone, M., Giordano, C., Leonildi, A., Barnini, S., Tiseo, G.

Journal: Clinical Infectious Diseases

Year: 2024

Real-world experience with meropenem/vaborbactam for the treatment of infections caused by ESBL-producing Enterobacterales and carbapenem-resistant Klebsiella pneumoniae

Authors: Tiseo, G., Galfo, V., Riccardi, N., Barnini, S., Falcone, M.

Journal: European Journal of Clinical Microbiology and Infectious Diseases

Year: 2024

Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa

Authors: Lee, S.Y., Gill, C.M., Nicolau, D.P., Fang, F., Thomson, G.

Journal: Journal of Antimicrobial Chemotherapy

Year: 2023

 

Dr. Hewang Lee, Medicinal Chemistry, Outstanding Scientist Award

Published on by Research Chemistry Awards

Dr. Hewang Lee, Medicinal Chemistry, Outstanding Scientist Award

Doctorate at George Washington University, United States

Professional Profile

Scopus

Orcid

🌟 Summary

  • Dr. Lihua is a seasoned Research Scientist at George Washington University, specializing in the metabolic mechanisms of hypertension and chronic kidney diseases. With a robust background spanning prestigious institutions like NIH and Max-Planck Institute, Dr. Lihua has made significant contributions to understanding renal regulation, energy metabolism, and neuropeptide functions.

🎓 Education

  • Ph.D. in Medical Science, Beijing Medical University, 1997
  • M.S. in Medical Science, Shanghai Medical University, 1993
  • M.D. in Clinical Medicine, Bengbu Medical College, 1990

👩‍🔬 Professional Experience

  • Research Scientist, George Washington University, 2020 – Present
    • Leading projects on NPFF, SNX19, PRDX4, and autophagy in hypertension.
  • Statistical Analyst and Programmer, Rang Technologies, 2019 – 2020
    • Clinical research in oncology, cardiovascular, and renal diseases.
  • Researcher, Dalian Medical University, 2015 – 2018
    • Investigated metabolic mechanisms in chronic kidney diseases.
  • Postdoc Scientist, University of Maryland and Children National Medical Center, 2009 – 2015
    • Explored sodium reabsorption regulation and GPCR trafficking in hypertension.

🔍 Research Interests

  • Hypertension mechanisms
  • Neuropeptides and dopamine interactions
  • Autophagy and renal diseases

Publication Top Noted📝

  • Article: Poly-(ADP-ribose) polymerases inhibition by olaparib attenuates activities of the NLRP3 inflammasome and of NF-κB in THP-1 monocytes
    • Authors: Mustafa, K., Han, Y., He, D., Lee, H., Qu, P.
    • Journal: PLoS ONE
    • Volume: 19
    • Issue: 2 (February)
    • Pages: e0295837
    • Year: 2024
  • Article: Peroxiredoxin-4 and Dopamine D5 Receptor Interact to Reduce Oxidative Stress and Inflammation in the Kidney
    • Authors: Amatya, B., Yang, S., Yu, P., Lee, H., Jose, P.A.
    • Journal: Antioxidants and Redox Signaling
    • Volume: 38
    • Issue: 16
    • Pages: 1150–1166
    • Year: 2023
  • Article: RNA-Seq analysis of obese Pdha1fl/flLyz2-Cre mice induced by a high-fat diet
    • Authors: Geng, Z., Yuan, Y., He, D., Tang, Z., Qu, P.
    • Journal: Experimental Animals
    • Volume: 72
    • Issue: 1
    • Pages: 112–122
    • Year: 2023
  • Article: The Correlation between Increased Expressions of NLRP3 Inflammasome Components in Peripheral Blood Mono-Nuclear Cells and Plaque Vulnerability in Human Carotid Atherosclerosis
    • Authors: Xie, W., Shi, X., Lee, H., Niu, N., Qu, P.
    • Journal: Iranian Journal of Public Health
    • Volume: 52
    • Issue: 1
    • Pages: 147–158
    • Year: 2023
  • Article: HIV-1 Vpr suppresses expression of the thiazide-sensitive sodium chloride cotransporter in the distal convoluted tubule
    • Authors: Shrivastav, S., Lee, H., Okamoto, K., Kino, T., Kopp, J.B.
    • Journal: PLoS ONE
    • Volume: 17
    • Issue: 9 (September)
    • Pages: e0273313
    • Year: 2022